University of Leicester
Browse
journal.pone.0023081.pdf (427.51 kB)

Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection.

Download (427.51 kB)
journal contribution
posted on 2012-10-24, 09:11 authored by M. Bonnet, M. Pardini, F. Meacci, G. Orrù, Hasan Yesilkaya, T. Jarosz, Peter W. Andrew, Mike Barer, F. Checchi, H. Rinder, G. Orefici, S. Rüsch-Gerdes, L. Fattorini, M. R. Oggioni, J. Melzer, S. Niemann, F. Varaine
Introduction Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. Methods We combined drug susceptibility results and molecular strain typing data with treatment outcome reports to assess the influence of drug resistance on TB treatment outcomes in a prospective cohort of patients from Abkhazia (Georgia). Patients received individualized treatment regimens based on drug susceptibility testing (DST) results. Definitions for antituberculosis drug resistance and treatment outcomes were in line with current WHO recommendations. First and second line DST, and molecular typing were performed in a supranational laboratory for Mycobacterium tuberculosis (MTB) strains from consecutive sputum smear-positive TB patients at baseline and during treatment. Results At baseline, MTB strains were fully drug-susceptible in 189/326 (58.0%) of patients. Resistance to at least H or R (PDR-TB) and multidrug-resistance (MDR-TB) were found in 69/326 (21.2%) and 68/326 (20.9%) of strains, respectively. Three MDR-TB strains were also extensively resistant (XDR-TB). During treatment, 3/189 (1.6%) fully susceptible patients at baseline were re-infected with a MDR-TB strain and 2/58 (3.4%) PDR-TB patients became MDR-TB due to resistance amplification. 5/47 (10.6%) MDR- patients became XDR-TB during treatment. Treatment success was observed in 161/189 (85.2%), 54/69 (78.3%) and 22/68 (32.3%) of patients with fully drug susceptible, PDR- and MDR-TB, respectively. Development of ofloxacin resistance was significantly associated with a negative treatment outcome. Conclusion In Abkhazia, a region with high prevalence of drug resistant TB, the use of individualized MDR-TB treatment regimens resulted in poor treatment outcomes and XDR-TB amplification. Nosocomial transmission of MDR-TB emphasizes the importance of infection control in hospitals.

Funding

The study was supported by the European Community grant QLK-CT-2002-01612 (LONG-DRUG study).

History

Citation

PLoS ONE, 2011, 6 (8), pp. e23081-e23081

Published in

PLoS ONE

Publisher

Public Library of Science

issn

1932-6203

eissn

1932-6203

Copyright date

2011

Available date

2012-10-24

Publisher version

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023081

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC